MedKoo Cat#: 597417 | Name: Ici 216140
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

ICI 216140 is a GRP/bombesin receptor 2 antagonist (IC50 = 2 nM in vitro). At 2 mg/kg, it can reduce bombesin-stimulated pancreatic amylase secretion in rats. At 1 mM, it has been shown to attenuate bombesin-stimulated increases in blood pressure in rats. Bombesin is a peptide, originally isolated from the skin of the European fire-bellied toad, with pressor and sympathoexcitatory activity. Its three receptors are distributed throughout the central and peripheral nervous system and are involved in gastric acid secretion, emotional response, temperature control, learning, and memory. Neuromedin B and gastrin-releasing peptide (GRP) are mammalian homologs of bombesin.

Chemical Structure

Ici 216140
Ici 216140
CAS#124001-41-8

Theoretical Analysis

MedKoo Cat#: 597417

Name: Ici 216140

CAS#: 124001-41-8

Chemical Formula: C45H65N13O8

Exact Mass: 915.5079

Molecular Weight: 916.10

Elemental Analysis: C, 59.00; H, 7.15; N, 19.88; O, 13.97

Price and Availability

Size Price Availability Quantity
1mg USD 500.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Ici 216140; Ici-216140; Ici216140; m216140; m 216140; m-216140; N-Isobutyryl-his-trp-ala-val-ala-his-leu-nhme;
IUPAC/Chemical Name
(S)-2-((2S,5R,8S,11S,14S,17S)-2,17-bis((1H-imidazol-4-yl)methyl)-14-((1H-indol-3-yl)methyl)-8-isopropyl-N,5,11,20-tetramethyl-4,7,10,13,16,19-hexaoxo-3,6,9,12,15,18-hexaazahenicosanamido)-4-methylpentanamide
InChi Key
PPGUWGIPRTYEBI-QHOQUQLNSA-N
InChi Code
InChI=1S/C45H65N13O8/c1-23(2)14-36(38(46)59)58(9)45(66)35(17-30-20-48-22-51-30)56-40(61)26(7)53-44(65)37(24(3)4)57-41(62)27(8)52-42(63)33(15-28-18-49-32-13-11-10-12-31(28)32)55-43(64)34(54-39(60)25(5)6)16-29-19-47-21-50-29/h10-13,18-27,33-37,49H,14-17H2,1-9H3,(H2,46,59)(H,47,50)(H,48,51)(H,52,63)(H,53,65)(H,54,60)(H,55,64)(H,56,61)(H,57,62)/t26-,27+,33+,34+,35+,36+,37+/m1/s1
SMILES Code
CC(C)C[C@@H](C(N)=O)N(C([C@H](CC1=CNC=N1)NC([C@@H](C)NC([C@H](C(C)C)NC([C@H](C)NC([C@H](CC2=CNC3=C2C=CC=C3)NC([C@H](CC4=CNC=N4)NC(C(C)C)=O)=O)=O)=O)=O)=O)=O)C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info
Product Data
Biological target:
A GRP/bombesin receptor 2 antagonist.
In vitro activity:
Des-Met analogues showing potent antagonist activity in the in vitro 3T3 system (IC50 approximately 2nM) were synthesized. Further structural modification of these peptides led to the identification of (CH3)2CHCO-His-Trp-Ala-Val-D-Ala-His-Leu-NHCH3 (ICI 216140) which reduced bombesin-stimulated rat pancreatic amylase secretion to basal levels when administered subcutaneously at 2.0 mg per kg. Reference: Life Sci. 1989;45(17):1521-7. https://pubmed.ncbi.nlm.nih.gov/2555638/
In vivo activity:
The overall effect of ICI-216,140 (1 mM) was a significant attenuation of the rat MAP response to bombesin (P < 0.01). Similarly, the effect of ICI-216,140 on 300 μM bombesin was attenuated and measured 21 ± 7 mmHg (Fig. 2; P < 0.01). Reference: Am J Physiol Regul Integr Comp Physiol. 2011 Nov;301(5):R1486-94. https://pubmed.ncbi.nlm.nih.gov/21849634/
Solvent mg/mL mM
Solubility
DMF 2.0 2.18
DMSO 2.0 2.18
PBS (pH 7.2) 10.0 10.92
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 916.10 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Camble R, Cotton R, Dutta AS, Garner A, Hayward CF, Moore VE, Scholes PB. N-isobutyryl-His-Trp-Ala-Val-D-Ala-His-Leu-NHMe (ICI 216140) a potent in vivo antaconist analogue of bombesin/gastrin releasing peptide (BN/GRP) derived from the C-terminal sequence lacking the final methionine residue. Life Sci. 1989;45(17):1521-7. doi: 10.1016/0024-3205(89)90417-7. PMID: 2555638. 2. Zogovic B, Pilowsky PM. Intrathecal bombesin is sympathoexcitatory and pressor in rat. Am J Physiol Regul Integr Comp Physiol. 2011 Nov;301(5):R1486-94. doi: 10.1152/ajpregu.00297.2011. Epub 2011 Aug 17. PMID: 21849634.
In vitro protocol:
1. Camble R, Cotton R, Dutta AS, Garner A, Hayward CF, Moore VE, Scholes PB. N-isobutyryl-His-Trp-Ala-Val-D-Ala-His-Leu-NHMe (ICI 216140) a potent in vivo antaconist analogue of bombesin/gastrin releasing peptide (BN/GRP) derived from the C-terminal sequence lacking the final methionine residue. Life Sci. 1989;45(17):1521-7. doi: 10.1016/0024-3205(89)90417-7. PMID: 2555638.
In vivo protocol:
1. Zogovic B, Pilowsky PM. Intrathecal bombesin is sympathoexcitatory and pressor in rat. Am J Physiol Regul Integr Comp Physiol. 2011 Nov;301(5):R1486-94. doi: 10.1152/ajpregu.00297.2011. Epub 2011 Aug 17. PMID: 21849634.
1: Ryan RR, Taylor JE, Daniel JL, Cowan A. Pharmacological profiles of two bombesin analogues in cells transfected with human neuromedin B receptors. Eur J Pharmacol. 1996 Jun 13;306(1-3):307-14. PubMed PMID: 8813645. 2: Ryan RR, Daniel JL, Cowan A. Two bombesin analogues discriminate between neuromedin B- and bombesin-induced calcium flux in a lung cancer cell line. Peptides. 1993 Nov-Dec;14(6):1231-5. PubMed PMID: 8134305. 3: Camble R, Cotton R, Dutta AS, Garner A, Hayward CF, Moore VE, Scholes PB. N-isobutyryl-His-Trp-Ala-Val-D-Ala-His-Leu-NHMe (ICI 216140) a potent in vivo antaconist analogue of bombesin/gastrin releasing peptide (BN/GRP) derived from the C-terminal sequence lacking the final methionine residue. Life Sci. 1989;45(17):1521-7. PubMed PMID: 2555638. 4: Zogovic B, Pilowsky PM. Intrathecal bombesin is sympathoexcitatory and pressor in rat. Am J Physiol Regul Integr Comp Physiol. 2011 Nov;301(5):R1486-94. doi: 10.1152/ajpregu.00297.2011. Epub 2011 Aug 17. PubMed PMID: 21849634. 5: Campbell BJ, Garner A, Dockray GJ, Hughes J, Dimaline R. The mechanism of action of gastrin releasing peptide (GRP) in stimulating avian gastric acid secretion. Regul Pept. 1994 Jan 13;49(3):249-55. PubMed PMID: 8140277. 6: Campbell B, Garner A, Dimaline R, Dockray GJ. Hormonal control of avian pancreas by gastrin-releasing peptide from the proventriculus. Am J Physiol. 1991 Jul;261(1 Pt 1):G16-21. PubMed PMID: 1858884.